Trial site
Istanbul
- 12running trials
- 10closed trials
The trials here
What the 22 trials at this site are about, from their registry records.
- Conditions
- Multiple sclerosis6 trials
- Atopic dermatitis (eczema)4 trials
- Asthma3 trials
- Multiple myeloma3 trials
- Chronic rhinosinusitis with nasal polyps2 trials
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 trial
- Fabry disease1 trial
- Gastric and oesophageal cancer1 trial
- Haemophilia1 trial
- Phase
- Phase 317 trials
- Phase 24 trials
- Phase 2/31 trial
- Status
- Active, not recruiting10 trials
- Completed9 trials
- Enrolling by invitation1 trial
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Sanofi21 trials
- Genzyme, a Sanofi Company1 trial
Running trials
Active, not recruiting
Active, not recruiting
Enrolling by invitation
Long-term Safety and Efficacy Evaluation of Lunsekimig (SAR443765) in Adult Participants With Asthma
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Asthma1 recruiting
- CIDP (chronic inflammatory demyelinating polyneuropathy)1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Proof of Concept Study of Rilzabrutinib in Adult Participants With Moderate-to-severe Asthma
Terminated
Completed
Completed
Completed
Completed
Fitusiran Prophylaxis in Male Pediatric Subjects Aged 1 to Less Than 12 Years With Hemophilia A or B
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026